Core Viewpoint - Pro Pharmaceutical (000739) has signed a strategic cooperation framework agreement with Jiaxing Andikang Biotechnology Co., Ltd. to enhance long-term collaboration in innovative drug development and improve market competitiveness and supply stability [1] Group 1 - The agreement aims to establish a strategic partnership focused on innovative drug projects [1] - Both companies seek to enhance their competitive edge in the pharmaceutical industry through this collaboration [1] - The partnership is expected to strengthen the drug market's competitive advantages and ensure stable supply capabilities [1]

Core Viewpoint - Pro Pharmaceutical (000739) has signed a strategic cooperation framework agreement with Jiaxing Andikang Biotechnology to enhance long-term collaboration in innovative drug development, aiming to strengthen industry competitiveness and improve market supply capabilities [1] Company Summary - Pro Pharmaceutical is actively seeking to establish a strategic partnership with Jiaxing Andikang Biotechnology to explore more long-term projects in the field of innovative drugs [1] - The collaboration is focused on building competitive advantages in the pharmaceutical market and ensuring stable supply capabilities [1] Industry Summary - The agreement reflects a trend in the pharmaceutical industry towards strategic partnerships aimed at enhancing innovation and competitiveness [1] - The collaboration may lead to the development of new drug projects that could strengthen the overall market position of both companies [1]